Alpaca Registry Jun 2003 - Jan 2014
Vice President and Chief Scientist
Biohio Research Park the Ohio State University Jun 2003 - Jan 2014
President and Chief Executive Officer
Fluence Therapeutics May 2009 - Mar 2012
Chief Operations Officer
Austen Bioinnovation Institute In Akron 2009 - 2012
Director, Strategic Industry Innovation and Grants
Ninesigma Aug 2001 - May 2007
Vice President Operations and Program Managment
Education:
The University of Akron 1983 - 1987
Doctorates, Doctor of Philosophy, Biochemistry
The University of Akron 1981 - 1983
Master of Science, Masters, Chemistry
Purdue University 1973 - 1978
Bachelors, Bachelor of Science, Microbiology
Skills:
Biotechnology Product Development Entrepreneurship Commercialization Strategic Planning Program Management Business Development Leadership Technology Transfer Medical Devices Research Management R&D Business Strategy Project Management Team Building New Business Development Grant Writing Molecular Biology Budgets Drug Discovery Fundraising Chemistry Biochemistry Clinical Trials Training Drug Development Cell Open Innovation Patents Healthcare Intellectual Property Genomics Validation Innovation Management Immunology Knowledge Management Team Leadership Manufacturing Contract Negotiation Key Account Management Operations Management Customer Service Innovation Pharmaceuticals Budgeting Customer Relations Qc Problem Solving Writing
Shauna R. Brummet - Wadsworth OH Frank T. Robb - Silver Spring MD Kimberly M. Borges - Coventry CT Kristine M. Hujer - Cleveland OH Sally T. Domke - Parma OH
Assignee:
Amersham Life Science, Inc. - Cleveland OH
International Classification:
C12N 1563 C12N 1511 C12N 1555 C12N 916
US Classification:
4353201
Abstract:
Purified nucleic acid comprising a nucleotide base sequence selected from sequence ID NOS. : 1-9.